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Translating developmental origins 
of health and disease science to 
improve future health in Africa
At STIAS, the ‘Health in Transition’ theme includes a programme to address the epidemic 
rise in the incidence of non-communicable diseases (NCDs) such as Type 2 diabetes, 
hypertension, obesity, coronary heart disease and stroke in Africa. The aim is to advance 
awareness, research capacity and knowledge translation of science related to the 
Developmental Origins of Health and Disease (DOHaD) as a means of preventing NCDs in 
future generations.
Application of DOHaD science is a promising avenue for prevention, as this field is 
identifying how health and nutrition from conception through the first 1 000 days of life can 
dramatically impact a developing individual’s future life course, and specifically predicate 
whether or not they are programmed in infancy to develop NCDs in later life. 
Prevention of NCDs is an essential strategy as, if unchecked, the burden of caring for a 
growing and ageing population with these diseases threatens to consume entire health 
budgets, as well as negatively impact the quality of life of millions. 
Africa in particular needs specific, focussed endeavours to realise the maximal preventive 
potential of DOHaD science, and a means of generating governmental and public awareness 
about the links between health in infancy and disease in adult life. 
This volume summarises the expertise and experience of a leading group of international 
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Pregnancy diabetes is fast becoming a common condition across the world 
with developing countries particularly affected. In the short term, maternal 
hyperglycaemia worsens pregnancy outcomes, but in the long run, it appears to 
be a precursor to diabetes and cardiovascular disease in the mother and obesity 
and diabetes in the child. Thus, pregnancy diabetes is thought to contribute to 
the escalating epidemic of obesity and diabetes. Classic thinking is that pregnancy 
diabetes consists of pre-gestational diabetes and gestational diabetes. There are 
considerable confusion and controversy about the diagnosis and management of 
gestational diabetes. There is increasing evidence that risk factors and metabolic 
1 Diabetes Unit, King Edward Memorial Hospital and Research Center, Pune, India; 
Stellenbosch Institute for Advanced Study (STIAS), Wallenberg Research Centre at 
Stellenbosch University, Stellenbosch, South Africa.
2 Diabetes Unit.
3 Epidemiology Research Unit, CSI Holdsworth Memorial Hospital, Mysore, India.
4 Epidemiology Research Unit.
DIABETES IN PREGNANCY:  
LESSONS FOR DEVELOPING COUNTRIES
AJ Macnab, A Daar & C Pauw (eds). Health in Transition. Stellenbosch: African Sun Media
https://doi.org/10.18820/9781928357759/10 Copyright 2020 African Sun Media and STIAS
162      |  HEALTH IN TRANSITION
disturbances of gestational diabetes patients are present long before pregnancy, 
implicating peri-conceptional fetal programming of future obesity and diabetes. 
This chapter reviews what developing countries need to consider as a public health 
challenge in the context of gestational diabetes and how to contribute to research 
that will improve the understanding of the condition: biology, diagnosis, cost-
effective treatment, and long-term contribution to the health and economy of the 
nation. A lot can be learned from the experience of the developed world that will 
help to avoid the pitfalls plaguing this field. Forming a multinational consortium 
may improve the efficiency of such research. 
Gestational diabetes – definition and pathological aspects
The consensus definition of gestational diabetes is ‘carbohydrate intolerance of 
variable severity with onset or first recognition during pregnancy’, presenting 
several issues.5 The definition includes both ‘pregnancy-induced’ as well as 
undiagnosed pre-existing hyperglycaemia under gestational diabetes. Phenotypes 
strongly associated with diabetes such as obesity may have already been present in 
the majority of the  women who develop gestational diabetes. Also, this definition 
encompasses a wide range of glucose levels, including severe hyperglycaemia 
associated with newly discovered type 1 or type 2 diabetes mellitus in the same 
frame as mild hyperglycaemia characterising ‘pregnancy-induced’. This wide range 
of levels presents problems related to management guidelines during pregnancy 
and postpartum follow-up. The current World Health Organization (WHO) 
guidelines, thus, recommend categorising hyperglycaemia in pregnancy into ‘overt 
diabetes mellitus’ and ‘gestational diabetes’, the latter broadly corresponding to 
impaired fasting glucose or impaired glucose tolerance in the non-pregnant state.6 A 
diabetic pregnancy could thus be a pregnancy in a woman who already had diabetes 
(diagnosed or undiagnosed), or it may be because of hyperglycaemia purportedly 
induced by pregnancy. Notwithstanding these confusions, gestational diabetes is 
of concern because of adverse outcomes in the mother and the fetus. With a global 
rise in the prevalence of obesity and glucose intolerance among young people, 
5 Hadden, D.R. 1998. A historical perspective on gestational diabetes. Diabetes Care, 
21(Supplement 2):B3-B4. [https://www.ncbi.nlm.nih.gov/pubmed/9704219]; World 
Health Organization (WHO). 1999. Definition, diagnosis and classification of diabetes 
mellitus and its complications: Report of a WHO consultation. Part 1, Diagnosis and 
classification of diabetes mellitus. [https://apps.who.int/iris/handle/10665/66040].
6 WHO. 2013. Diagnostic Criteria and Classification of Hyperglycaemia First Detected 
in Pregnancy. Diabetes Programme. [https://www.who.int/diabetes/publications/
Hyperglycaemia_In_Pregnancy/en/].
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gestational diabetes is fast becoming a major public health problem, especially in 
transitioning populations such as India and Africa. 
Pregnancy is conventionally considered a diabetogenic condition. Gestational 
steroid hormones and placental lactogen promote insulin resistance which 
facilitates nutrient transfer to the fetus.7 Gestational diabetes is thought to occur 
when pancreatic β-cells fail to cope with the increased demands for insulin. Risk 
factors that impair the β-cell function (capacity) or exacerbate insulin resistance 
(load) facilitate the development of hyperglycaemia. These include maternal 
genetic predisposition (family history of diabetes), low birth weight or macrosomia 
at birth, advanced age, obesity, short stature, polycystic ovary syndrome, to name 
a few. It is noteworthy that except for a few pregnancy-related risk factors (excess 
weight gain in pregnancy, twin pregnancy, male fetus), the majority of risk factors 
are pre-pregnancy or intergenerational. These considerations indicate a substantial 
pre-pregnancy component for gestational diabetes. 
The last decade has seen considerable confusion and debates on diagnosis, 
management and short- and long-term implications of gestational diabetes. Some 
of these might be better understood by learning the history of ‘pregnancy and 
diabetes’. The first reports of the implications of hyperglycaemia in pregnancy for 
mother and baby were already available in the 1800s.8 These initial studies mainly 
described diabetic mothers who became pregnant and resulted in serious outcomes, 
including high rates of mortality in both mother and the baby. The invention of 
insulin in 1923 considerably reduced these extreme outcomes. Over the next many 
decades, the attention shifted to congenital anomalies and fetal overgrowth. In the 
1950s, Jorgen Pedersen first proposed a mechanism underlying accelerated fetal 
growth in diabetic pregnancies.9 In his classic ‘hyperglycaemia-hyperinsulinism’ 
hypothesis, he suggested that increased trans-placental transmission of glucose 
results in hypertrophy of fetal islet tissue and insulin hypersecretion. Fetal 
hyperinsulinemia stimulates growth and increases fetal size. In 1980, Norbert 
Freinkel extended this idea to include lipids and amino acids and suggested that 
insulin, as well as insuline-like growth factors, promote greater tissue anabolism and 
macrosomia.10 He suggested that this will also reflect on future obesity and diabetes 
(‘fuel-mediated teratogenesis’). The multinational Hyperglycaemia and Adverse 
7 Lain, K.Y. & Catalano, P.M. 2007. Metabolic changes in pregnancy. Clinical Obstetrics 
and Gynecology, 50(4):938-948. [https://doi.org/10.1097/GRF.0b013e31815a5494].
8 Hadden, 1998.
9 Pedersen, J. 1954. Weight and length at birth of infants of diabetic mothers. Acta 
Endocrinologica (Copenhagen), 16(4):330-342. [https://doi.org/10.1530/acta.0.0160330].
10 Freinkel, N. 1980. Banting Lecture 1980. Of pregnancy and progeny. Diabetes, 
29(12):1023-35. [https://doi.org/10.2337/diab.29.12.1023].
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Pregnancy Outcomes study supported this idea by demonstrating graded positive 
associations between maternal glycemia and neonatal weight, adiposity, and β-cell 
function across the range of glycemia that is not overt diabetes, at the same time 
posing challenges to the definition and management of gestational diabetes as a 
distinct entity.11 The current attention is thus focussed on milder degrees of glucose 
intolerance during pregnancy.12
Screening and diagnostic guidelines for gestational diabetes –  
the ongoing debate 
There is still a lack of consensus among scientists and clinicians on screening 
and diagnosis of gestational diabetes. The earlier definitions of gestational 
diabetes were based either on the prediction of future diabetes in the mother or 
were arbitrarily chosen to correspond to the oral glucose tolerance test criteria 
in non-pregnant individuals. In 1964, O’Sullivan and Mahan gave one of the first 
guidelines for diagnosing gestational diabetes using whole blood glucose levels 
during a three-hour 100g oral glucose tolerance test.13 These guidelines were 
similar to the definitions used for non-pregnant adults at that time and were aimed 
at identifying women with future risk of diabetes. In 1979, the National Diabetes 
Data Group proposed plasma glucose thresholds corresponding to the whole 
blood glucose thresholds to suit changes in laboratory methodology.14 These values 
were later lowered by Carpenter and Coustan (1982) who used specific enzymatic 
methods to measure glucose.15 In 1999, the WHO expert group recommended 
the use of plasma glucose values corresponding to impaired glucose tolerance in 
non-pregnant adults to diagnose gestational diabetes.16 However, none of these 
11 Metzger, B.E., Lowe, L.P., Dyer, A.R., Trimble, E.R., Chaovarindr, U., Coustan, D.R., 
Hadden, D.R., McCance, D.R., Hod, M., McIntyre, H.D., Oats, J.J., Persson, B., 
Rogers, M.S., Sacks, D.A., & HAPO Study Cooperative Research Group. 2008. 
Hyperglycaemia and adverse pregnancy outcomes. The New England Journal of Medicine, 
358(19):1991-2002. [https://doi.org/10.1056/NEJMoa0707943].
12 Mestman, J.H. 2002. Historical notes on diabetes in pregnancy. Endocrinologist, 
12(3):224-242. [https://doi.org/10.1097/00019616-200205000-00010].
13 O’Sullivan, J.B. & Mahan, C.M. 1964. Criteria for the oral glucose tolerance test in 
pregnancy. Diabetes, 13:278-285. [https://www.ncbi.nlm.nih.gov/pubmed/14166677].
14 National Diabetes Data Group. 1979. Classification and diagnosis of diabetes mellitus and 
other categories of glucose intolerance. Diabetes, 28(12):1039-1057.  
[https://doi.org/10.2337/diab.28.12.1039].
15 Carpenter, M.W. & Coustan, D.R. 1982. Criteria for screening tests for gestational 
diabetes. American Journal of Obstetrics and Gynecology, 144(7):768-773.  
[https://doi.org/10.1016/0002-9378(82)90349-0].
16 WHO, 1999.
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definitions considered the effect of glucose thresholds on short- and long-term 
fetal outcomes.
The Hyperglycaemia and Adverse Pregnancy Outcomes study focused on the 
‘short term’ (perinatal) outcomes in the mother and baby.17 This large multi-
centric study observed a graded linear relationship between fasting, one-hour 
and two-hour glucose values during the oral glucose tolerance test (24-28 weeks) 
and a range of pre-defined pregnancy outcomes, particularly offspring birth 
weight. In 2010, the International Association of Diabetes and Pregnancy Study 
Group proposed diagnostic guidelines based on the Hyperglycaemia and Adverse 
Pregnancy Outcomes findings.18 To translate the above continuous associations 
into diagnostic thresholds, cut-off values that represent an odds ratio of 1.75 for 
the outcome of the highest decile of birth weight and cord C-peptide were chosen 
by consensus.19 However, Hyperglycaemia and Adverse Pregnancy Outcomes 
researchers agree that this is an arbitrary definition. These values, based on the 
increased risk of fetal macrosomia in developed populations, need to be interpreted 
with caution in countries like India, where small-for-gestational-age births are 
prevalent even in pregnancies complicated by gestational diabetes.20
The WHO and the International Federation of Gynaecology and Obstetrics 
accepted the criteria of the International Association of Diabetes and Pregnancy 
Study Group.21 However, many other organisations have not. The screening 
17 Metzger et al., 2008.
18 Metzger, B.E., Gabbe, S.G., Persson, B., Lowe, L.P., Dyer, A.R., Oats, J.J.N. & 
Buchanan, T.A. 2010. International association of diabetes and pregnancy study groups 
recommendations on the diagnosis and classification of hyperglycaemia in pregnancy. 
Diabetes Care, 33(3):676-82. [https://doi.org/10.2337%2Fdc09-1848].
19 Metzger et al., 2010.
20 McIntyre, H.D., Metzger, B.E., Coustan, D.R., Dyer, A.R., Hadden, D.R., Hod, M., 
Lowe, L.P., Oats, J.J. & Persson, B. 2014. Counterpoint: Establishing consensus in the 
diagnosis of GDM following the HAPO study. Current Diabetes Reports, 14(6):497. 
[https://doi.org/10.1007/s11892-014-0497-x]; Elizabeth, K.E., Ashwin, D.A., 
Sobhakumar, S. & Sujatha, T.L.2018. Large and Small-for-Gestational-Age (LGA 
and SGA) Babies born to Mothers with Pre-Pregnancy/Gestational Diabetes Mellitus 
(PPDM/GDM) Vs. No-DM. Acta Scientific Paediatrics, 1(3):23-28. [https://www.
actascientific.com/ASPE/pdf/ASPE-01-0020.pdf ]; Elango, S., Sankarasubramanian, 
M.L. & Marimuthu, B. 2018. An observational study of clinical profile of infants born 
to pregestational and gestational diabetic mothers. International Journal of Contemporary 
Pediatrics, 5(2):557-562. [https://doi.org/10.18203/2349-3291.ijcp20180554].
21 WHO, 2013; Hod, M., Kapur, A., Sacks, D.A., Hadar, E., Agarwal, M., Di Renzo, G.C., 
Cabero Roura, L., McIntyre, H.D., Morris, J.L., Divakar, H. 2015. The International 
Federation of gynecology and Obstetrics (FIGO) Initiative on gestational diabetes 
mellitus: A pragmatic guide for diagnosis, management, and care. International Journal of 
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guidelines also vary. Some recommend one stage universal screening of pregnant 
women (75g oral glucose tolerance test, the WHO and the International Federation 
of Gynaecology and Obstetrics) while others recommend a 50g challenge followed 
by a definitive oral glucose tolerance test. Some recommend only selective 
testing (high-risk groups: such as a family history of diabetes, obesity and high 
prevalence ethnicity). 
Indian guidelines
In the absence of a national guideline for gestational diabetes diagnosis, there has 
been a lack of uniformity in screening and diagnostic criteria among healthcare 
providers in India. In 2005, the Diabetes in Pregnancy Study Group in India 
proposed a one-step non-fasting glucose tolerance test and the diagnosis based on 
the 120-minutes plasma glucose value of more than 140mg/dl.22 This proposition 
was justified for its logistic convenience and is endorsed by the Federation of 
Obstetric and Gynaecological Societies of India. There is a paucity of data for 
perinatal and long-term outcomes and efficacy of diagnosis and treatment. 
Changing trends in gestational diabetes prevalence:  
diagnostic criteria vs. secular trends
All these different diagnostic guidelines continue to baffle the average clinician. 
One of the major implications of changing thresholds has been the different 
detection rates of gestational diabetes. The rates are highest using criteria of the 
International Association of Diabetes and Pregnancy Study Group because of the 
lowest glucose thresholds and the requirement for only a single abnormal value 
during the oral glucose tolerance test.23 Some researchers argue that this may be one 
of the factors for the higher prevalence of gestational diabetes observed in recent 
studies.24 Another recent study in Demark contended that the WHO 2013 criteria 
Gynecology and Obstetrics, 131(Supplement 3):173-211. [https://doi.org/10.1016/S0020-
7292(15)30033-3].
22 Seshiah, V., Das, A.K., Balaji, V., Joshi, S.R., Parikh, M.N. & Gupta, S. & Diabetes 
in Pregnancy Study Group. 2006. Gestational diabetes mellitus-guidelines. The Journal 
of the Association of Physicians of India, 54:622-628. [https://www.ncbi.nlm.nih.gov/
pubmed/16941793].
23 Li, K.T., Naik, S., Alexander, M. & Mathad, J.S. 2018. Screening and diagnosis of 
gestational diabetes in India: a systematic review and meta-analysis. Acta Diabetologica, 
55(6):613-625. [https://doi.org/10.1007/s00592-018-1131-1].
24 Cundy, T. 2012. Proposed new diagnostic criteria for gestational diabetes--a pause 
for thought? Diabetic Medicine, 29(2):176-180. [https://doi.org/10.1111/j.1464-
5491.2011.03407.x]; Vinter, C.A., Tanvig, M.H., Christensen, M.H., Ovesen, P.G., 
AJ Macnab, A Daar & C Pauw (eds). Health in Transition. Stellenbosch: African Sun Media
https://doi.org/10.18820/9781928357759/10 Copyright 2020 African Sun Media and STIAS
Diabetes in pregnancy:  lessons for developing countries  |      167
might not be suitable for their population because they inappropriately label a large 
number of women with low or no risk as gestational diabetes.25
The prevalence of type 2 diabetes is increasing rapidly in the world and affecting 
the young, particularly in transitioning populations.26 With a rise in obesity and 
glucose intolerance among women of reproductive ages, a parallel rise in the 
prevalence of gestational diabetes is anticipated. Currently, the global prevalence 
of gestational diabetes stands at ~16 per cent, which corresponds to the global rates 
of glucose intolerance in non-pregnant women of reproductive age.27 These figures 
appear even more dramatic in transitioning populations such as India. In the 
1980s-1990s, the rates of gestational diabetes were low (one to five per cent) while 
recent reports have quoted figures up to 20 per cent. While it is conceivable that 
there is a real rise in the incidence, differences in oral glucose tolerance test criteria 
complicate interpretation. The highest rates were observed using the International 
Association of Diabetes and Pregnancy Study Group’s criteria. The Diabetes in 
Pregnancy Study Group in India’s estimates is ~25 per cent lower compared to 
the International Association of Diabetes and Pregnancy Study Group’s criteria.28 
Despite these difficulties in interpretation, some facts are consistent: higher 
maternal age, urban residence and overweight are associated with higher prevalence. 
In the Pune Maternal Nutrition Study, data is available in mother-daughter pairs 
over 20 years and shows a many-fold increase in the incidence of pregnancy 
hyperglycaemia in the daughter. Importantly, pregnancy glycemia was significantly 
associated with childhood and adolescent glycemia, suggesting that the so-called 
gestational diabetes women have metabolic abnormalities from early childhood. 
Given the importance of pre and periconceptional maternal nutritional in ‘fetal 
programming’ of diabetes and other non-communicable diseases, diagnosing and 
Jørgensen, J.S., Andersen, M.S., McIntyre, H.D. & Jensen, D.M. 2018. Lifestyle 
intervention in Danish obese pregnant women with early gestational diabetes mellitus 
according to WHO 2013 criteria does not change pregnancy outcomes: Results from the 
LiP (Lifestyle in Pregnancy) Study. Diabetes Care, 41(10):2079-2085.  
[https://doi.org/10.2337/dc18-0808].
25 Vinter et al., 2018.
26 International Diabetes Federation (IDF). 2015. IDF Diabetes Atlas 7th Edition (2015). 
[https://bit.ly/38wj43I].
27 International Diabetes Federation (IDF). 2011. Diabetes in Pregnancy: Protecting Maternal 
Health. Policy Briefing. [https://bit.ly/35lgVWP].
28 Tripathi, R., Verma, D., Gupta, V. K., Tyagi, S., Kalaivani, M., Ramji, S. & Mala Y.M. 
2017. Evaluation of 75 g glucose load in non-fasting state [Diabetes in Pregnancy Study 
group of India (DIPSI) criteria] as a diagnostic test for gestational diabetes mellitus. 
Indian Journal of Medical Research, 145(2):209-214. [https://doi.org/10.4103/ijmr.
IJMR_1716_15].
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treating gestational diabetes in late pregnancy may be like closing the door after the 
horse has bolted. 
It will be crucial to document effects of glycemia and other metabolites (‘fuels’) on 
short- and long-term outcomes both in the mother and the child in the developing 
countries where malnutrition is still common to understand the significance of 
diagnosis and treatment of gestational diabetes. 
Implications of gestational diabetes for the mother
Gestational hyperglycaemia is associated with several maternal morbidities. These 
include increased vulnerability to infections, preterm and caesarean deliveries with 
their associated risks to the mother, and trauma associated with fetal macrosomia 
and shoulder dystocia.29 Women with gestational diabetes are also more likely to 
have preeclampsia. Many of these morbidities may have a common risk factor, 
i.e. obesity. 
Type 2 diabetes is one of the most commonly observed long-term outcomes 
among gestational diabetes women. A recent review showed that 2.6 to 70 per cent 
of women with gestational diabetes had diabetes when examined six weeks to 28 
years postpartum, respectively.30 Though few, Indian studies have noted a high 
prevalence of diabetes in postnatal follow up of gestational diabetes women. Using 
data from a diabetic clinic, Kale and colleagues (Yajnik, Kulkarni, Meenakumari, 
Joglekar, Khorsand, Ladkat, Ramdas and Lubree, 2004) showed that more than 50 
per cent of the gestational diabetes women had diabetes when followed 4.5 (± two) 
years after delivery.31 In a hospital-based cohort study in Mysore, the prevalence 
of diabetes was 37 per cent in the gestational diabetes women as opposed to two 
per cent among the women without gestational diabetes five years after delivery.32 
29 Kjos, S.L. & Buchanan, T.A. 1999. Gestational Diabetes Mellitus.  
The New England Journal of Medicine, 341(23):1749-1756.  
[https://doi.org/10.1056/NEJM199912023412307].
30 Kim, C., Newton, K.M. & Knopp, R.H. 2002. Gestational Diabetes and the Incidence of 
Type 2 Diabetes A systematic review. Diabetes Care, 25(10):1862-1868.  
[https://doi.org/10.2337/diacare.25.10.1862].
31 Kale, S., Yajnik, C., Kulkarni, S., Meenakumari, K., Joglekar, A., Khorsand, N., 
Ladkat, R.S., Ramdas, L.V. & Lubree, H.G. 2004. High risk of diabetes and metabolic 
syndrome in Indian women with gestational diabetes mellitus. Diabetics Medicine, 
21(11):1257-1258. [https://doi.org/10.1111/j.1464-5491.2004.01337.x].
32 Krishnaveni, G., Hill, J., Veena, S., Geetha, S., Jayakumar, M., Karat, C. & Fall, C.H.D. 
2007. Gestational diabetes and the incidence of diabetes in the 5 years following the index 
pregnancy in South Indian women. Diabetes Research and Clinical Practice, 78(3):398-404. 
[https://doi.org/10.1016%2Fj.diabres.2007.06.002].
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Nearly 60 per cent of the gestational diabetes women also had features of metabolic 
syndrome (versus 26 per cent in women without gestational diabetes), suggesting 
an increased cardiovascular risk. In a recent study conducted in two obstetric 
units in New Delhi and Hyderabad, 72 per cent of the women with gestational 
diabetes were found to have dysglycaemia within five years of delivery including 
32 per cent with type 2 diabetes.33 In the Women in India with GDM Strategy 
(WINGS) study, jointly undertaken by the International Diabetes Federation 
and the Madras Diabetes Research Foundation, 15 per cent of the women, were 
found to have dysglycaemia within 12 weeks of delivery.34 Age and body mass index 
status are the key predictors. It may indicate that 12 weeks may be too early to 
capture abnormalities.
The tracking of glucose from early childhood through pregnancy suggests that the 
so-called gestational diabetes and post-delivery diabetes are part of a life-course 
evolution of the metabolic abnormality and suggests against gestational diabetes 
and the subsequent diabetes being de novo conditions. Notwithstanding these 
issues, it is imperative to follow up gestational diabetes women for glucose and 
cardiovascular risk and advise appropriate preventive measures and treatment.
Implications of gestational diabetes for the offspring
Maternal hyperglycaemia increases the risk of adverse fetal outcomes. Severe 
diabetes in the mother during pregnancy is known to increase the risk of early fetal 
loss, congenital anomalies and neonatal mortality.35 Less-severe hyperglycaemia 
is associated with fetal macrosomia and adiposity.36 Macrosomia may hinder 
33  Gupta, Y., Kapoor, D., Desai, A., Praveen, D., Joshi, R., Rozati, R., Bhatla, N., 
Prabhakaran, D., Reddy, P., Patel, A. & Tandon, N. 2017. Conversion of gestational 
diabetes mellitus to future type 2 diabetes mellitus and the predictive value of HBA1C in 
an Indian cohort. Diabetic Medicine, 34(1):37-43. [https://doi.org/10.1111/dme.13102].
34 Bhavadharini, B., Anjana, R., Mahalakshmi, M., Maheswari, K., Kayal, A., 
Unnikrishnan, R. Ranjani, H., Ninov, L., Pastakia, S.D., Usha, S., Malanda, B., 
Belton, A., Uma, R. & Mohan, V. 2016. Glucose tolerance status of Asian Indian women 
with gestational diabetes at 6 weeks to 1year postpartum (WINGS-7). Diabetes Research 
and Clinical Practice, 117:22-27. [https://doi.org/10.1016/j.diabres.2016.04.050].
35 Balsells, M., García-Patterson, A., Gich, I. & Corcoy, R. 2012. Major congenital 
malformations in women with gestational diabetes mellitus: a systematic review and 
meta-analysis. Diabetes/Metabolism Research and Reviews, 28(3):252-257.  
[https://doi.org/10.1002/dmrr.1304]; Schaefer, U., Songster, G., Xiang, A., Berkowitz, K., 
Buchanan, T. & Kjos, S. 1997. Congenital malformations in offspring of women with 
hyperglycaemia first detected during pregnancy. American Journal of Obstetrics and 
Gynecology, 177(5):1165-1171. [https://doi.org/10.1016/s0002-9378(97)70035-8].
36 Plows, J., Stanley, J., Baker, P., Reynolds, C. & Vickers, M. 2018. The Pathophysiology 
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vaginal delivery, exposing both the mother and the fetus to operative risks; a 
serious example is shoulder dystocia. Other neonatal complications include 
neonatal hypoglycaemia, polycythaemia, hyperbilirubinemia, hypocalcaemia and 
respiratory distress syndrome.37
However, it is the long-term implications of gestational diabetes in the offspring, 
which is the current global focus. It has been long observed that exposure to 
maternal diabetes in utero predisposes an individual to subsequent obesity and 
diabetes. Studies in Pima Indians of Arizona, America showed a substantial 
contribution of maternal diabetes to higher rates of early obesity and diabetes in 
the offspring.38 These studies highlighted that offspring associations were mainly 
due the intra-uterine hyperglycaemia rather than genes or shared post-natal 
environment by showing that risks were considerably higher in offspring of diabetic 
mothers than offspring of diabetic fathers or pre-diabetic mothers (mothers 
who developed diabetes after delivery and thus were genetically predisposed).39 
Subsequently, several other studies have confirmed that the Pima Indian findings 
apply to other populations.40
of Gestational Diabetes Mellitus. International Journal of Molecular Sciences, 19(11):3342. 
[https://doi.org/10.3390%2Fijms19113342].
37 Kjos &Buchanan, 1999.
38 Dabelea, D. & Pettitt, D.J. 2001. Intrauterine diabetic environment confers risks for 
type 2 diabetes mellitus and obesity in the offspring, In addition to genetic susceptibility. 
Journal of Pediatric Endocrinology and Metabolism, 14(8):1085-1091.  
[https://doi.org/10.1515/jpem-2001-0803].
39 Dabelea & Pettitt, 2001; Pettitt, D.J., Bennett, P.H., Knowler, W.C., Baird, H.R. & 
Aleck, K.A. 1985. Gestational Diabetes Mellitus and impaired glucose tolerance during 
pregnancy: long-term effects on obesity and glucose tolerance in the offspring. Diabetes, 
34(Supplement 2):119-122. [https://doi.org/10.2337/diab.34.2.s119].
40 Silverman, B.L., Metzger, B.E., Cho, N.H. & Loeb, C.A. 1995. Impaired Glucose 
Tolerance in Adolescent Offspring of Diabetic Mothers: Relationships to foetal 
Hyperinsulinism. Diabetes Care, 18(5):611-617. [https://doi.org/10.2337/
diacare.18.5.611]; Vohr, B.R., McGarvey, S.T., Tucker, R. 1999. Effects of maternal 
gestational diabetes on offspring adiposity at 4-7 years of age. Diabetes Care, 
22(8):1284-1291. [https://doi.org/10.2337/diacare.22.8.1284]; Clausen, T.D., 
Mathiesen, E.R., Hansen, T., Pedersen, O., Jensen, D.M., Lauenborg, J. & Damm, P. 
2008. High prevalence of type 2 diabetes and pre-diabetes in adult offspring of 
women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine 
hyperglycaemia. Diabetes Care, 31(2):340-346. [https://doi.org/10.2337/dc07-1596]; 
Philipps, L.H., Santhakumaran, S., Gale, C., Prior, E., Logan, K.M., Hyde, M.J. & 
Modi N. 2011. The diabetic pregnancy and offspring BMI in childhood: a systematic 
review and meta-analysis. Diabetologia, 54(8):1957-1966. [https://doi.org/10.1007/
s00125-011-2180-y]; Aceti. A., Santhakumaran, S., Logan, K.M., Philipps, L.H., 
Prior, E., Gale, C., Hyde, M.J. & Modi, N. 2012. The diabetic pregnancy and offspring 
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The developmental origins of health and disease (DOHaD) hypothesis proposes 
that impaired nutrition during fetal development increases an individual’s 
susceptibility to non-communicable disease in later life.41 This phenomenon is 
thought to reflect the permanent effects of disturbed fetal nutrition on structural 
and physiological systems (‘programming’). It was initially described by David 
Barker and colleagues (Hales, Fall, Osmond, Phipps and Clark, 1998) in a 
retrospective cohort of people born in Hertfordshire where they demonstrated that 
lower birth weight predisposed to a higher risk of diabetes and related conditions.42 
Implications of maternal nutrition and metabolism for the baby:  
Indian evidence
Research in India suggests that programming by maternal nutritional and 
metabolic imbalances may be an important factor driving the non-communicable 
disease epidemic. Specifically, cohort studies in Pune and Mysore have shown 
that micronutrient imbalances are common among pregnant Indian women 
(related to among other iron, vitamin B12, folate, vitamin D), and have proposed 
that intrauterine nutrient deficiencies could alter structural and functional 
characteristics of the offspring (nutrient mediated teratogenesis).43 On the other 
blood pressure in childhood: a systematic review and meta-analysis. Diabetologia, 
55(11):3114-3127. [https://doi.org/10.1007/s00125-012-2689-8].
41 Barker, D.J., Gluckman, P.D., Godfrey, K.M., Harding, J.E., Owens, J.A. & 
Robinson, J.S. 1993. Fetal nutrition and cardiovascular disease in adult life. The Lancet, 
341(8850):938-941. [https://doi.org/10.1016/0140-6736(93)91224-a].
42 Barker, D.J.P. 1998. Mothers, babies and health in later life. 2nd Edition. London: 
Churchill Livingstone; Barker, D.J.P., Hales, C.N., Fall, C.H.D., Osmond, C., Phipps, K. 
& Clark, P.M.S. 1993. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension 
and hyperlipidaemia (syndrome X): relation to reduced foetal growth. Diabetologia, 
36(1):62-67. [https://doi.org/10.1007/bf00399095].
43 Yajnik, C.S., Deshpande, S.S., Jackson, A.A., Refsum, H., Rao, S., Fisher, D.J., 
Bhat, D.S., Naik, S.S., Coyaji, K.J., Joglekar, C.V., Joshi, N., Lubree, H.G., 
Deshpande, V.U., Rege, S.S., & Fall, C.H.D. 2008. Vitamin B12 and folate 
concentrations during pregnancy and insulin resistance in the offspring: the Pune 
Maternal Nutrition Study. Diabetologia, 51:29-38. [https://doi.org/10.1007%2Fs00125-
007-0793-y]; Krishnaveni, G.V., Veena, S.R., Winder, N.R., Hill, J.C., Noonan, K., 
Boucher, B.J., Karat, S.C. & Fall, C.H.D. 2011. Maternal vitamin D status during 
pregnancy and body composition and cardiovascular risk markers in Indian children: 
the Mysore Parthenon study. The American Journal of Clinical Nutrition, 93(3):628-635. 
[https://doi.org/10.3945/ajcn.110.003921]; Yajnik, C.S. 2009. Nutrient-mediated 
teratogenesis and fuel-mediated teratogenesis: two pathways of intrauterine programming 
of diabetes. International Journal of Gynecology & Obstetrics, 104(Supplement 1):27-31. 
[https://doi.org/10.1016/j.ijgo.2008.11.034].
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hand, owing to rapid socio-economic development (urbanisation) young women 
are becoming increasingly adipose, insulin resistant and glucose-intolerant during 
pregnancy, contributing to a rapidly rising incidence of gestational diabetes among 
both rural and urban women. Micronutrient deficiencies and gestational diabetes 
may co-exist in the same women, thereby exposing the growing fetus to multiple 
programming pathways (Dual Teratogenesis) (Figure 10.2 and 10.3).44
The initial evidence for possible programming effect of maternal hyperglycaemia 
in India came from a birth cohort study at the Holdsworth Memorial Hospital in 
Mysore.45 This study showed that adult men and women with type 2 diabetes were 
more likely to be shorter and fatter at birth (higher ponderal index) and were born 
to women with higher weight and larger pelvic diameters. There were no glucose 
measurements, but it was postulated that these mothers might have been glucose 
intolerant.46 It was hypothesised that widespread fetal growth retardation in India 
predisposes individuals to insulin resistance, and leads to glucose intolerance 
in pregnant women if exposed to obesogenic environments that accompany 
urbanisation. Thus, maternal under-nutrition results in diabetes in the next 
generation, which in the case of female offspring manifests as gestational diabetes, 
thus perpetuating the risk cycle. 
The Mysore Parthenon Study is a purpose-designed hospital-based prospective 
birth cohort established to examine the life-course predictors of non-
communicable diseases in hyperglycaemic pregnancies. As expected, neonates of 
gestational diabetes mothers were heavier, longer and more adipose than control 
babies (offspring of a non-gestational diabetes mother and non-diabetic father).47 
There was a clustering of cardiovascular risk markers, including adiposity, higher 
glucose, insulin resistance (based on homeostasis model assessment: HOMA-
IR) and blood pressure in offspring of diabetic mothers during childhood and 
44 Yajnik et al., 2009; Krishnaveni, G.V., Hill, J.C., Veena, S.R., Bhat, D.S., Wills, A.K., 
Karat, C.L.S., Yajnik, C.S. & Fall, C.H.D. 2009. Low plasma vitamin b12 in pregnancy is 
associated with gestational ‘diabesity’ and later diabetes. Diabetologia, 52(11):2350-2358. 
[https://doi.org/10.1007/s00125-009-1499-0].
45 Fall, C.H.D., Stein, C.E., Kumaran, K., Cox, V., Osmond. C., Barker, D.J. & 
Hales, C.N. 1998. Size at birth, maternal weight, and non-insulin-dependent diabetes 
(NIDDM) in South Indian adults. Diabetic Medicine, 15(3):220-227. [https://doi.
org/10.1002/(SICI)1096-9136(199803)15:3%3C220::AID-DIA544%3E3.0.CO;2-O].
46 Fall et al., 1998.
47 Hill, J.C., Krishnaveni, G.V., Annamma, I., Leary, S.D. & Fall, C.H.D. 2005.  
Glucose tolerance in pregnancy in South India: Relationships to neonatal anthropometry. 
Acta Obstetricia et Gynecologica Scandinavica, 84(2):159-165. [https://doi.org/10.1111/
j.0001-6349.2005.00670.x].
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adolescence.48 The difference in subcutaneous adiposity between offspring of 
diabetic mothers and offspring of non-diabetic mothers continued to increase 
across childhood (Figure 10.1). The Parthenon study showed for the first time that 
maternal diabetes programmes neuroendocrine stress responses in the offspring, 
suggesting that this may be one of the pathways for their greater cardiovascular 
risk.49 Adolescent offspring of diabetic mothers exhibited greater systolic blood 
pressure, cardiac output, and stroke volume responses than control offspring to a 
standardised psychosocial stressor that involved performing public speaking and 
mental arithmetic tasks in front of a panel of two adult ‘judges’ (Trier Social Stress 
Test).50 In all these associations, effects were stronger for several risk outcomes 
among offspring of diabetic mothers than in the offspring of diabetic fathers 
suggesting an independent role of intrauterine hyperglycaemia in addition to 
genetic influences. 
The Pune Maternal Nutrition Study described the influence of maternal size, 
physical nutrition activity on fetal growth and future risk of diabetes. The study 
started 25 years ago when undernutrition was the major theme in rural India. The 
average mother in the Pune Maternal Nutrition Study had a body mass index of 
18.1kg/m2, and only an occasional mother had gestational diabetes. In these thin 
and normoglycemic pregnancies, maternal circulating glucose, cholesterol, high-
density lipoprotein cholesterol and triglyceride concentrations were significant 
predictors of neonatal size and body composition.51 The babies weighed an 
average 2.7kg but had higher adiposity (subscapular skinfold, and abdominal fat) 
compared to an English baby weighing 3.5kg.52 This ‘thin-fat’ Indian baby also had 
48 Krishnaveni, G.V., Hill, J.C., Leary, S.D., Veena, S.R., Saperia, J., Saroja, A., Karat, S.C. 
& Fall, C.H. 2005. Anthropometry, glucose tolerance, and insulin concentrations 
in Indian children: relationships to maternal glucose and insulin concentrations 
during pregnancy. Diabetes Care, 28(12):2919-2925. [https://doi.org/10.2337/
diacare.28.12.2919]; Krishnaveni, G.V., Veena, S.R., Hill, J.C., Kehoe, S., Karat, S.C. 
& Fall, C.H. 2010. Intra-uterine exposure to maternal diabetes is associated with 
higher adiposity and insulin resistance and clustering of cardiovascular risk markers in 
Indian children. Diabetes Care, 33(2):402-404. [https://doi.org/10.2337/dc09-1393]; 
Krishnaveni, G.V., Veena, S.R., Jones, A., Srinivasan, K., Osmond, C., Karat, S.C., 
Kurpad, A.V. & Fall, C.H. 2015. Exposure to maternal gestational diabetes is associated 
with higher cardiovascular responses to stress in adolescent Indians. The Journal of Clinical 
Endocrinology and Metabolism, 100(3):986-993. [https://doi.org/10.1210/jc.2014-3239].
49 Krishnaveni et al., 2015.
50 Krishnaveni et al., 2015.
51 Kulkarni, S., Kumaran, K., Rao, S., Chougule, S., Deokar, T., Bhalerao, A., Solat, V.A., 
Bhat, D.S., Fall, C.H. & Yajnik, C.S. 2013. Maternal Lipids Are as Important as Glucose 
for Fetal Growth. Diabetes Care, 36(9):2706-2713. [https://doi.org/10.2337/dc12-2445].
52 Yajnik, C.S., Fall, C.H., Coyaji, K.J., Hirve, S.S., Rao, S., Barker, D.J., Joglekar, C. 
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elevated cord blood concentrations of leptin and insulin but lower adiponectin, 
suggesting intrauterine programming of fetal body composition and endocrine 
axes by small maternal size and undernutrition. The Mysore study and studies 
in migrant Indians in the UK and Canada showed that the thin-fat phenotype is 
exaggerated by maternal hyperglycaemia.53 The follow-up studies in Pune showed 
that the cardio-metabolic risk factors are highest in children who were born ‘light’ 
but grew ‘heavy’ during childhood and adolescence, even though not obese by 
international standards.54 Such a ‘mismatch’ pattern of growth represents the double 
burden of malnutrition within a lifetime with serious consequences for the risk of 
non-communicable diseases. One of the maternal nutritional imbalances, which 
influenced fetal growth, body composition and diabetes risk was a coexistence of 
the low vitamin B12 and high folate status.55 This low status may be ascribed to a 
vegetarian diet (deficient for vitamin B12 but rich for folates) and the iatrogenic use 
of high dose folic acid to prevent anaemia and neural tube defects, a practice based 
on folic acid trials in B12 adequate western populations. This policy ignored that 
vitamin B12 deficiency may have a major role in aetiology of neural tube defects 
in Indians. In the Mysore study, maternal body mass index and glycemia were 
inversely related to plasma vitamin B12 concentrations, suggesting a double burden 
of malnutrition (micronutrient deficiency, macronutrient excess).56 We proposed 
that such a combination of risk factors promotes a ‘dual teratogenesis’ (Figure 10.2 
and 10.3) which will exaggerate fetal programming of non-communicable diseases 
& Kellingray, S. 2003. Neonatal anthropometry: the thin-fat Indian baby. The Pune 
Maternal Nutrition Study. International Journal of Obesity and Related Metabolic Disorders, 
27(2):173-180. [https://doi.org/10.1038/sj.ijo.802219].
53 Krishnaveni et al., 2010; Anand, S., Gupta, M., Schulze, K., Desai, D., Abdalla, N., 
Wahi, G., Wade, C., Scheufler, P., McDonald, S.D., Morrison, K.M., Vasudevan, A., 
Dwarakanath, P., Srinivasan, K., Kurpad, A., Gerstein, H.C. & Teo, K.K. 2015. What 
accounts for ethnic differences in newborn skinfold thickness comparing South Asians and 
White Caucasians? Findings from the START and FAMILY Birth Cohorts. International 
Journal of Obesity, 40(2):239-244. [https://doi.org/10.1038/ijo.2015.171]; Lawlor, D., 
West, J., Fairley, L., Nelson, S., Bhopal, R., Tuffnell, D., Freeman, D.J., Wright, J., 
Whitelaw, D.C. & Sattar, N. 2014. Pregnancy glycaemia and cord-blood levels of 
insulin and leptin in Pakistani and white British mother-offspring pairs: findings from a 
prospective pregnancy cohort. Diabetologia, 57(12):2492-2500. [https://doi.org/10.1007/
s00125-014-3386-6].
54 Yajnik, C.S., Joglekar, C.V., Pandit, A.N., Bavdekar, A.R., Bapat, S.A., Bhave, S.A., 
Leary, S.D. & Fall, C.D. 2003. Higher Offspring Birth Weight Predicts the Metabolic 
Syndrome in Mothers but Not Fathers 8 Years after Delivery: The Pune Children’s Study. 
Diabetes, 52(8):2090-2096. [https://doi.org/10.2337/diabetes.52.8.2090].
55 Yanik et al., 2008.
56 Krishnaveni et al., 2009.
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and that such a situation may be common in many countries in Africa, increasing 
the burden of obesity and diabetes at a young age.57
The India GDM study at the Diabetes Unit, KEM Hospital, Pune followed up 
children born to diabetic and non-diabetic mothers two to 26 years after delivery.58 
We confirmed the elevated risk of obesity, adiposity, diabetes and other cardio-
metabolic risk factors in the young children of diabetic compared to non-diabetic 
pregnancies. Interestingly, parental (both maternal and paternal) size and glucose 
intolerance had a mirror image effect on obesity-adiposity and glucose intolerance 
in the child, maternal glucose had an additional effect on obesity-adiposity of 
the child.59
Does maternal hyperglycaemia have any beneficial effect on the fetus? Brain 
preservation is a fundamental driver of fetal growth and has a priority over other 
structures in adverse conditions.60 Previous studies (mostly in pre-gestational 
uncontrolled diabetic pregnancies) reported compromised cognitive abilities 
in offspring of diabetic mothers compared to control offspring.61 Interestingly, 
in the Parthenon study, maternal hyperglycaemia was associated with better 
cognitive function in offspring of diabetic mothers, which persisted after 
controlling for confounding factors like parental education and socio-economic 
status.62 Notwithstanding residual confounding, an interesting possibility is that 
extra fuel supply to the developing fetus may enhance brain development in an 
otherwise undernourished pregnancy. In such situations, gestational diabetes 
may have evolutionary benefits for fetal survival. There is a need for expanding 
57 Yajnik, 2009.
58 Wagle, S., Kumaran, K., Ladkat, R., Bhat, D., Yajnik, P. & Yajnik, C. 2018. Comparison 
of Cardio-metabolic Risk Factors in Offspring Of Diabetic Mothers (ODM) And 
Nondiabetic Mothers (ONDM) In India. Diabetes, 67(Supplement 1).  
[https://doi.org/10.2337/db18-1418-P].
59 Wagle et al., 2018.
60 Yajnik, C.S. 2004. Obesity epidemic in India: intrauterine origins? Proceedings of the 
Nutrition Society, 63(3):387-396. [https://doi.org/10.1079/pns2004365].
61 Dionne, G., Boivin, M., Séguin, J.R., Pérusse, D. & Tremblay, R.E. 2008. Gestational 
diabetes hinders language development in offspring. Pediatrics, 122(5):e1073-9.  
[https://doi.org/10.1542/peds.2007-3028]; Ornoy, A. 2005. Growth and 
neurodevelopmental outcome of children born to mothers with pregestational and 
gestational diabetes. Pediatric Endocrinology Reviews, 3(2):104-113.  
[https://bit.ly/38uvlpz].
62 Veena, S.R., Krishnaveni, G.V., Srinivasan, K., Kurpad, A.V., Muthayya, S., Hill, J.C., 
Kiran, K.N. & Fall, C.H.D. 2010. Childhood cognitive ability: relationship to gestational 
diabetes mellitus in India. Diabetologia, 53(10):2134-2138. [https://doi.org/10.1007/
s00125-010-1847-0].
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these investigations in the developing countries, and also to study ‘cost-benefit’ of 
maternal gestational diabetes to put a proper perspective on this condition which is 
rapidly escalating. 
Gestational diabetes management and effects on offspring risk
The majority of evidence linking maternal diabetes with offspring adiposity and 
glucose intolerance is observational. There is a potential for confounding by many 
factors. Two randomised clinical trials of glycaemic control in gestational diabetes 
women: the Australian Carbohydrate Intolerance Study in Pregnant Women and 
the National Institutes of Health trials in late pregnancy demonstrated a reduction 
in fetal macrosomia and associated perinatal morbidity (shoulder dystocia, 
neonatal hypoglycaemia).63 Despite this, there is little evidence for the reduction of 
childhood obesity in both the trials. Interestingly, there was a reduction of fasting 
glycemia and insulin resistance in girls in the National Institutes of Health trial 
but not in the boys (post hoc analysis). There is an urgent need for the follow up 
of children born in various pregnancy trials to establish the long-term benefits of 
treating mild gestational diabetes. It is also imperative to confirm the findings in 
relatively undernourished populations, and foetuses are growth restricted (small-
for-gestational-age) because the treatment of gestational diabetes is invariably 
associated with a reduction in the baby’s size. 
Are we missing the window?
Preconceptual and early pregnancy periods are crucial for ovum growth 
and development, ovulation, fertilisation, implantation, placentation and 
organogenesis. Even a small alteration in the intrauterine ‘milieu’ during this 
period could have substantial effects on these processes and phenotype of the 
fetus.64 There is now a growing understanding on the role of maternal nutrition and 
63 Crowther, C., Hiller, J., Moss, J., McPhee, A., Jeffries, W., Robinson, J. & Australian 
Carbohydrate Intolerance Study in Pregnant Women Trial Group. 2005. Effect of 
Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes. New England 
Journal of Medicine, 352(24):2477-2486. [https://doi.org/10.1056/NEJMoa042973]; 
Landon, M., Spong, C., Thom, E., Carpenter, M., Ramin, S., Casey, B. Wapner, R.J., 
Varner, M.W., Rouse, D.J., Thorp, J.M. Jr., Sciscione, A., Catalano, P., Harper, M., 
Saade, G., Lain, K.Y., Sorokin, Y., Peaceman, A.M., Tolosa, J.E. & Anderson, G.B. & 
Eunice Kennedy Shriver National Institute of Child Health and Human Development 
Maternal-Fetal Medicine Units Network. 2009. A Multicenter, Randomized Trial 
of Treatment for Mild Gestational Diabetes. New England Journal of Medicine, 
361(14):1339-1348. [https://doi.org/10.1056/NEJMoa0902430].
64 Stephenson, J., Heslehurst, N., Hall, J., Schoenaker, D.A.J.M., Hutchinson, J., Cade, J.E., 
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metabolism in the preconceptual period on the maturation of oocytes, optimising 
gamete function and thus embryo potential with consequences for the long-term 
health of the offspring.65 The epigenetic ‘reprogramming’, happening soon after 
fertilisation, may also be influenced by any pre-existing maternal conditions. Thus, 
pre-gestational nutrition and metabolism could have a major programming effect 
on the embryo even before gestational diabetes has been recognised. 
The current practice of screening for gestational diabetes in the third trimester of 
pregnancy is based on experience in low prevalence western populations many 
decades ago. The ‘yield’ was supposed to be highest at this time point in pregnancy, 
for which metabolic-endocrine explanations were suggested.66 However, the 
majority of women diagnosed with gestational diabetes had elevated glucose in 
early pregnancy even in an American clinic, suggesting a substantial contribution 
of pregestational glucose intolerance.67 It is noteworthy that a comparable 
prevalence of glucose intolerance in young non-pregnant American women to 
that in pregnant women led to a suggestion in 1988 that gestational diabetes could 
represent undiagnosed pre-gestational hyperglycaemia.68 Interestingly, John Jarrett 
asserted that gestational diabetes is ‘an incidental pregnancy in a woman with 
glucose intolerance’.69
Poston, L., Barrett, G., Crozier, S.R., Barker, M., Kumaran, K., Yajnik, C.S., Baird, J. & 
Mishra, G.D. 2018. Before the beginning: nutrition and lifestyle in the preconception 
period and its importance for future health. The Lancet, 391(10132):1830-1841.  
[https://doi.org/10.1016/S0140-6736(18)30311-8].
65 Fleming, T.P., Watkins, A.J., Velazquez, M.A., Mathers, J.C., Prentice, A.M., 
Stephenson, J., Barker, M., Saffery, R., Yajnik, C.S., Eckert, J.J., Hanson, M.A., 
Forrester, T., Gluckman, P.D. & Godfrey, K.M. Origins of lifetime health around the time 
of conception: causes and consequences. The Lancet, 391(10132):1842-1852.  
[https://doi.org/10.1016/S0140-6736(18)30312-X]; Metzger, B.E., Coustan, D.R. & 
Organizing Committee. 1980. Summary and Recommendations. American Diabetes 
Association’s First International Gestational Diabetes Workshop. Diabetes Care, 3(3):499-501.  
[https://care.diabetesjournals.org/content/diacare/3/3/499.full.pdf ].
66 Metzger, Coustan & Organizing Committee, 1980; Moyer, V. & U.S. Preventive Services 
Task Force. 2014. Screening for gestational diabetes mellitus: U.S. Preventive Services Task 
Force recommendation statement. Annals of Internal Medicine, 160(6):414-420.  
[https://doi.org/10.7326/M13-2905].
67 Super, D., Edelberg, S., Philipson, E., Hertz, R. & Kalhan, S. 1991. Diagnosis of 
gestational diabetes in early pregnancy. Diabetes Care, 14(4):288-294.  
[https://doi.org/10.2337/diacare.14.4.288].
68 Harris, M.I. 1988. Gestational diabetes may represent discovery of preexisting glucose 
intolerance. Diabetes Care, 11(5):402-411. [https://doi.org/10.2337/diacare.11.5.402].
69 Jarrett, R.J. 1993. Gestational diabetes: a non-entity? BMJ, 306(6869):37-38.  
[https://doi.org/10.1136%2Fbmj.306.6869.37].
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A substantial range of risk factors for gestational diabetes (obesity, central 
obesity, dysglycaemia, dyslipidaemia, non-alcoholic fatty liver disease, chronic 
inflammation, polycystic ovarian syndrome and other endocrine disturbances) are 
present pre-gestationally and track from childhood into adult age.70 Thus, most of 
the risk of gestational diabetes is already present before conception and exposes 
the fetus to adverse conditions in the peri-conceptional period. Presence of a large 
fetus, polyhydramnios and higher abdominal wall obesity in the fetus on ultrasound 
examination at the time of diagnosis of gestational diabetes suggests ongoing 
hyperglycaemia from early pregnancy.71 Reported higher prevalence of neural 
tube defects and other congenital anomalies in gestational diabetes pregnancies 
also suggests peri-conceptional metabolic disturbance.72 Studies observing pre-
pregnancy factors such as weight gain up to pregnancy, lipoprotein abnormalities 
and mild dysglycemia in relation to the risk of GDM provide further support to 
a pre-existing susceptibility to glucose intolerance in these women.73 We suggest 
that the so-called gestational diabetes in the high-risk developing populations of 
the world may represent undiagnosed pregestational diabetes in a substantial 
proportion of cases. This possibility needs to be tested in a wider population in 
different countries to revise the policy for the timing of screening for ‘pregnancy’ 
70 Han, E., Krauss, R., Xu, F., Sridhar, S., Ferrara, A., Quesenberry, C. & Hedderson, M.M. 
2016. Pre-pregnancy adverse lipid profile and subsequent risk of gestational diabetes.  
The Journal of Clinical Endocrinology and Metabolism, 101(7):2721-2727.  
[https://doi.org/10.1210/jc.2015-3904]; Solomon, C., Willett, W.C., Carey, V.J., 
Rich-Edwards, J., Hunter, D.J., Colditz, G.A., Stampfer, M.J., Speizer, F.E., 
Spiegelman, D. & Manson, J.E. 1997. A Prospective Study of Pre-gravid Determinants 
of Gestational Diabetes Mellitus. Journal of the American Medical Association, 
278(13):1078-1083. [https://doi.org/10.1001/jama.1997.03550130052036]; McClain, 
M., Srinivasan, S., Chen, W., Steinmann, W. & Berenson, G. 2000. Risk of Type 2 
Diabetes Mellitus in Young Adults from a Biracial Community: The Bogalusa Heart 
Study. Preventive Medicine, 31(1):1-7. [https://doi.org/10.1006/pmed.2000.0682].
71 Venkataraman, H., Ram, U., Craik, S., Arungunasekaran, A., Seshadri, S. & Saravanan, P. 
2016. Increased fetal adiposity prior to diagnosis of gestational diabetes in South Asians: 
more evidence for the ‘thin- fat’ baby. Diabetologia, 60(3):399-405.  
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hyperglycaemia. Interestingly, a pre-conceptional supplement with micronutrient-
rich snack reduced the incidence of gestational diabetes in the Mumbai slums.74
Given that the majority of risk factors of gestational diabetes are initiated early in 
life, the prevention measures should start during adolescence to target lifestyle 
factors such as diet, physical activity and stress management. The rapidly increasing 
prevalence of obesity in the young is an obvious target for prevention, but the 
improvement of general and micronutrient nutrition in the undernourished is 
equally important. The measures to improve birth weight in malnourished 
populations should be carefully followed up as the effect of increased neonatal size 
on its body composition, and future risk of diabetes is not yet clear. We need to 
keep in mind the possibility that the measures to shift birth weight upward across 
the range may inadvertently increase adiposity in the absence of specific nutrient 
supply to the growing fetus. 
Conclusion and research agenda
Even as the prevalence of gestational diabetes and its adverse consequences are 
on the rise in India and other developing countries, there is no clear direction for 
screening, diagnosis, management and long-term follow-up of mothers and their 
offspring. In particular, there is a need for investigation to see if international 
criteria are applicable for both the short-term and long-term outcomes in different 
populations, keeping an open mind on possible adverse effects of the treatment itself 
in certain situations. The current standards of management of gestational diabetes 
are challenging in resource-poor settings (rural India and in underprivileged urban 
pregnancies). The challenges are multiple and predominantly driven by limited 
awareness among patients and primary care physicians, poverty, the paucity of 
specialist clinicians, non-affordability and limited availability of medication and 
glucose monitoring facilities. 
On this background, developing countries have a great opportunity to learn from 
history and contribute to a better understanding of fetal programming in a situation 
of rapidly evolving double burden of malnutrition, also guiding some of the ‘double 
duty’ actions to blunt the effect of rapid transition on the escalating epidemic of 
diabetes and other related non-communicable diseases. 
74 Sahariah, S., Potdar, R., Gandhi, M., Kehoe, S., Brown, N., Sane, H., Coakley, P.J., 
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One way to achieve these is to form a consortium of developing countries to 
improve pregnancy outcomes. The international DOHaD society may be able to 
coordinate such efforts. Some of the objectives could be to: 
  Establish pre-conceptional birth cohorts to collect relevant information and 
create a biobank to study life-course evolution of health and disease, including 
research in clinics and community, with an eye on translation.
  Revisit the issues related to definition and diagnosis of gestational diabetes: 
glucose dose, timing, cut points, short- and long-term outcomes. The criteria 
need to be evidence-based, need-based and pragmatic given the continuous 
nature of associations and therefore, impossible to agree on an arbitrary 
threshold.
  Evolve strategies for the treatment of pregnancy diabetes in resource-poor 
settings, specific for the region, cultural-religious factors, socio-economic 
conditions and will broadly follow the aim of ‘personalised’ medicine. It will 
be crucial to remember the principle of ‘do no harm’ given the large burden 
of fetal undernutrition in diabetic pregnancies in the transition situations, 
introducing maternal food restrictions may do unexpected harm.
Figure 10.1 Subscapular skinfold thickness in (a) offspring of diabetic mothers  
(ODM) and (b) offspring of diabetic fathers (ODF) compared to control offspring.  
Bars represent subscapular thickness in the Parthenon cohort children at each year 
from birth to 15 years of age; ODM: black bars; Control Offspring: white bars; ODF: grey 
bars.*P less than 0.05 for comparison between ODM and Controls and ODF and controls. 
The difference in subscapular skinfold thickness between ODM and controls continued to 
increase as the children aged (a); a similar increase was not seen in ODF (b).
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Figure 10.2 Dual Teratogenesis: fetal programming in rapid transition. 
Interrelationship of two major maternal factors (undernutrition and overnutrition) in fetal 
programming. An undernourished mother produces a small (thin–fat) insulin resistant 
baby. If this baby remains undernourished in postnatal life; the cycle is proliferated. If the 
thin-fat insulin resistant baby is over-nourished, it becomes obese and hyperglycemic. 
An obese and hyperglycemic mother produces a “macrosomic” baby at higher risk of 
obesity and hyperglycemia. Rapid transition shifts the balance from undernutrition to 
overnutrition and contributes to the escalation of the diabetes epidemic.
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Figure 10.3 The proposed mechanisms in the ‘dual teratogenesis’ in a diabetic  
pregnancy in the developing countries, an example of dual burden of malnutrition. 
In developing countries, a rapid nutritional transition is creating unique situations 
in pregnancy. There is a coexistence of excess ‘fuels’ (high glucose, amino acids and 
lipids) along with deficiencies and imbalances of ‘micronutrients’ (vitamin B12, Folate, 
Iron, Calcium and vitamin D). This transition puts in motion a ‘dual teratogenesis’ 
in the developing fetus promoting growth disturbances, excess adiposity and other 
problems. In the long-term, these ‘programming’ influences promote the development 
of non-communicable diseases like diabetes and cardiovascular disease. These effects 
are mediated both by direct fuel transfer and accumulation and also by epigenetic 
mechanisms such as DNA methylation, histone modification and miRNAs. Pre-conception 
and pregnancy are the most prominent windows for such intergenerational influences.
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